Federal contract award
75F40122C00051
DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE SEQUELAE OF COVID19
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $2.0M |
| Current contract value | $2.0M |
| Potential contract value / ceiling | $2.0M |
| Start date | Jun 17, 2022 |
| Current end date | Jun 16, 2024 |
| Potential end date | Jun 16, 2024 |
| Latest award activity | Jun 28, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 28, 2026 | P00003 | $-261.0K | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. |
| Jun 12, 2024 | P00002 | $0 | DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE SEQUELAE OF COVID19 |
| May 11, 2023 | P00001 | $1.7M | DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE SEQUELAE OF COVID19 |
| Jun 17, 2022 | 0 | $559.4K | DEVELOPMENT OF A MODEL THAT INTEGRATES INFLAMMATION AND TISSUE INJURY TO PREDICT AND MITIGATE THE POST-ACUTE SEQUELAE OF COVID19 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.